Board of Directors

As a venture capitalist, Heller was instrumental in the formation of the Bluegrass Angels, a central Kentucky venture capital fund; was chairman of the board of managers for the Bluegrass Angels Venture Fund; has been active in the Lexington Venture Club, a group of business people organized to help entrepreneurs meet potential investors.

As a state government official, Heller served two years from 1991 to 1993 under then-Kentucky Governor Brereton Jones as secretary of the Cabinet for Human Resources, where he oversaw and made policy governing six departments and 15,000 state employees.

At the university level, Heller has served as a part-time professor in UK's Martin School of Public Policy and Public Administration since 1996. From 1983 to 1986, he was vice chancellor for academic affairs at UK's Albert B. Chandler Medical Center, and from 1977 to 1983, he was assistant dean of educational development at the UK College of Medicine, where he was also as a professor of behavioral science. In addition, Heller has been on the faculties of the University of Illinois, the University of Michigan and Baylor College of Medicine, and held administrative positions at the University Of Michigan College Of Medicine.

He serves on the board of Health Kentucky, a non-profit corporation that provides free pharmaceuticals and physician visits to underprivileged Kentuckians who are not Medicaid-eligible.

Heller holds an Ed.D. in administration and organizational development from Kansas University.

Mr. Fallone brings to the Coldstream board successful entrepreneurial, executive and leadership experience in technically complex manufacturing operations gained largely in the pharmaceutical and process industries. He held various executive leadership positions in Sterling Drug, culminating as Division President of Sterling Organics where he oversaw Sterling’s API internal and contract manufacturing operations in the US, Puerto Rico and the UK. He later became the Vice President of US Operations for NycomedAmersham, overseeing their US API, Injectable, Aerosols and Solid Dosage manufacturing operations serving both internal and contract based customers. In 1999 Mr. Fallone led a successful $60 Million management buyout of the Nycomed Amersham API facility in Rensselear NY forming the new contract manufacturing company Organichem. Under Mr. Fallone’s leadership Organichem grew significantly, branching into high potency and controlled substance manufacturing and piloting/clinical supply process development.Organichem was ultimately successfully sold to an investor. Since Organichem, Mr. Fallone has continued to consult and invest in various entrepreneurial manufacturing businesses and is currently serving as the President and CEO of Electro Metrics, an antenna and RF equipment manufacturing company that largely serves the US government. Mr. Fallone graduated from Clarkson College of Technology in 1975 with a BS in Mechanical Engineering. Prior to Sterling Drug, Mr. Fallone also held various engineering positions with Shell Chemical Company and General Electric.

Mr. Sexton brings to Coldstream’s Board his experience as an innovative and entrepreneurial executive with over 29 years of broad industry experience and proven abilities in strategic planning, tactical execution, staff development and creation of team based environments. He has specific experience in developing and leading start-up companies to success, as well as streamlining and positioning mid to large international pharmaceutical companies for growth into the 21st century. He is the Founder and President of New World Pharmaceuticals, LLC, a privately held specialty pharmaceuticalcompany focused on the development of novel delivery and patient interface systems. Before starting New World Pharmaceuticals, Mr. Sexton spent over four years with Purdue Pharma L.P., ultimately becoming the Senior Vice President, Technical Operations and Non-Clinical R&D. Prior to Purdue Mr. Sexton was part of the start-up team of Kos Pharmaceuticals, Inc. where he was the Sr Vice President of Technical Operations and Product Development. In this capacity he helped build the company from its infancy through its IPO and into a successful fully integrated pharmaceutical company. In addition to his Purdue and Kos assignments he spent 12 years with Boehringer Ingelheim Pharmaceuticals in various management positions both domestically and internationally; and four years with Ayerst Laboratories in pre-clinical research and pilot plant management positions. Mr. Sexton is a former member of the Board of Directors of the International Society of Pharmaceutical Engineers (ISPE) and the ISPE International Leadership Forum. He was the Chair and chief editor of ISPE’s Good Practice Guide for Technology Transfer. Mr. Sexton holds as BS from Clarkson College of Technology. He is a member of Clarkson University’s School of Arts and Sciences Advisory Board. Mr. Sexton has multiple issued and pending formulation, drug delivery and device patents.

Dr. Tim Tracy is a native of South Webster, Ohio. Dr. Tracy received his bachelor’s degree in pharmacy from Ohio Northern University and began his career as a pharmacist in Gallipolis and Portsmouth, Ohio, before returning to school to receive his doctoral degree. He received his Ph.D. in clinical pharmacy from Purdue University, and completed a postdoctoral fellowship in clinical pharmacology at Indiana University.

Dr. Tracy began his academic career at West Virginia University where he served as a faculty member working his way from assistant professor to professor from 1992 to 2003. In 2003, he joined the faculty at the University of Minnesota as professor and was named department head in 2004. In 2010, Dr. Tracy was named Dean of the University of Kentucky College of Pharmacy. He started at UK in August 2010.